China's Sinovac evaluates vaccine plant in Chile

Chilean authorities said on Friday that China's Sinovac had begun evaluating potential sites for the construction of a vaccine plant in Chile that could begin producing doses of the Chinese shot as early as the first half of 2022. Chile, a global leader in vaccinating its citizens against the coronavirus, has leaned heavily on the Sinovac vaccine in its fast-paced mass vaccination program. The Andean nation also helped spearhead clinical trials of the shot late last year. A delegation of executives from Sinovac this week visited potential sites for the factory near the capital Santiago and in Chile's northern desert.